Shuttle Pharmaceuticals borrows $250k from CEO at 12% interest, repayable in 12 months

Shuttle Pharmaceuticals Holdings, Inc.

Issued $250,000 promissory note to CEO Anatoly Dritschilo on September 4, 2024.
Interest accrues at 12% per annum simple interest; principal and interest due in 12 equal monthly installments.
Final payment due September 4, 2025; default rate increases to 20%.
Loan proceeds provide working capital; CEO is the sole lender.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.